Blog
RSS FeedPosted by Michael Wonder on 05 Sep 2019
What is the value of market-wide health care price transparency?
5 September 2019 - A primary driver of high spending in the US health care system, relative to other countries, ...
Posted by Michael Wonder on 04 Sep 2019
Capital Rx to inject transparency in prescription drug prices
4 September 2019 - In recent years, the pharmacy benefits management industry's pricing practices have been under intense scrutiny by ...
Posted by Michael Wonder on 25 Aug 2019
Time for FDA to release complete responses letters? Debate reignites.
23 August 2019 - The idea of the US FDA releasing complete response letters resurfaced this week as Sarepta Therapeutics ...
Posted by Michael Wonder on 21 Aug 2019
Appealing court ruling, Trump administration renews fight to require drug prices in TV ads
21 August 2019 - The Trump administration isn’t giving up the fight to require drug makers include their sticker prices ...
Posted by Michael Wonder on 19 Aug 2019
Extension to feedback for public consultation - standardised redactions of PBAC Public Summary Documents
19 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers and ...
Posted by Michael Wonder on 18 Aug 2019
Lack of transparency hampers cancer drug debate
19 August 2019 - The current debate raging over cancer drug funding is emotional, and the different agenda of lobby ...
Posted by Michael Wonder on 08 Aug 2019
Insurers snooping in our health records
9 August 2019 - Life insurers have trawled through the medical records of 150,000 Australians in an attempt to deny ...
Posted by Michael Wonder on 02 Aug 2019
Public consultation – standardised redactions of Public Summary Documents
2 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers ...
Posted by Michael Wonder on 01 Aug 2019
Proposal to enhance the transparency of CADTH’s review reports and recommendations
31 July 2019 - CADTH is committed to increasing the transparency of its health technology assessment processes. ...
Posted by Michael Wonder on 30 Jul 2019
CMS announces landmark price transparency proposals that benefit consumers
29 July 2019 - Additional proposed rules advance agency’s patients over paperwork and meaningful measures initiatives, strengthen quality incentives, and ...
Posted by Michael Wonder on 22 Jul 2019
2019 October price disclosure cycle - indicative prices
22 July 2019 - Indicative 1 October 2019 prices resulting from the 2019 October cycle of price disclosure have now been ...
Posted by Michael Wonder on 10 Jul 2019
A Supreme Court ruling may have made it harder to get some info from the FDA
9 July 2019 - Anyone seeking certain information about a medicine from the FDA may have a harder time getting ...
Posted by Michael Wonder on 02 Jul 2019
Will transparent pricing make America’s health care cheaper?
29 June 2019 - A new executive order requires hospitals and insurers to disclose their negotiated prices. ...
Posted by Michael Wonder on 02 Jul 2019
Drug price TV ad rule will cause consumer confusion, drug makers argue
2 July 2019 - Three drug makers on Monday urged a federal judge to block a new Trump administration rule ...
Posted by Michael Wonder on 28 Jun 2019
Recommendations made by the PBAC - May 2019 intracycle meeting
28 June 2019 - The Department of Health has published an update of the outcomes from the May 2019 PBAC ...